Nan Chen

Biostatistician I
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center

Presentation(s):

• VPB0279 - Anti-factor Xa-based risk stratification of children receiving therapeutic enoxaparin is associated with increased risk of recurrent/progressive thrombosis and hemorrhage: a retrospective cohort study

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM